Judge Blocks Health Secretary Kennedy's Proposed Changes to Childhood Vaccine Schedule

Developing StoryLast updated MAR 16
SUMMARY

A U.S. District Court judge has temporarily blocked proposed changes to the childhood vaccination schedule, including reducing the number of recommended shots and removing the hepatitis B vaccine for all babies, initiated by Health Secretary Robert F. Kennedy Jr. The ruling, issued on March 16, 2026, also halts further votes on vaccine policy changes and invalidates appointments to the CDC's vaccine committee, finding that Kennedy's actions likely violated federal law. The American Academy of Pediatrics and other health groups filed the lawsuit, and the Trump administration is expected to appeal the decision, indicating an ongoing legal battle over federal vaccine policy.

Timeline

Want updates on this thread?

Track this story

2026

7 updates

A U.S. District Court judge issued a temporary injunction, effectively blocking Health Secretary Robert F. Kennedy Jr.'s proposed changes to the childhood vaccine schedule. The ruling specifically halted further votes on vaccine policy changes by the Advisory Committee on Immunization Practices (ACIP) and invalidated Kennedy's appointments to the committee, finding that his actions likely violated federal law. This significant legal setback for the Trump administration temporarily preserves the existing childhood immunization guidelines and prevents the implementation of the controversial new schedule.

via forbes.com·axios.com·theguardian.com

The Department of Justice, representing the Department of Health and Human Services (HHS) and Secretary Kennedy, presented its defense in federal court. Government lawyers argued that the Secretary acted within his executive authority to reform advisory committees and that the proposed vaccine schedule changes were based on a re-evaluation of scientific data. They contended that the court should not interfere with the executive branch's discretion in public health policy.

via axios.com·theguardian.com·firstwordpharma.com

Legal arguments commenced in a U.S. District Court regarding the lawsuit filed by the American Academy of Pediatrics and allied medical groups against Health Secretary Kennedy and HHS. Plaintiffs argued that Kennedy had overstepped his statutory authority by unilaterally dismissing and appointing ACIP members and that the proposed vaccine schedule changes lacked scientific basis. The court began to hear evidence regarding the procedural irregularities and potential public health consequences of the administration's actions.

via axios.com·theguardian.com·firstwordpharma.com

In response to the proposed federal changes, several U.S. states announced their intention to maintain their existing, more comprehensive childhood immunization schedules, regardless of federal guidance. State health departments and governors expressed concerns about public health risks and the potential for increased disease transmission. This created a complex and fragmented landscape of vaccine policy across the nation, with states preparing to defy federal recommendations.

via axios.com·theguardian.com·firstwordpharma.com

In a unified front, major medical and public health organizations, including the American Academy of Pediatrics (AAP), the American Medical Association (AMA), and the Infectious Diseases Society of America (IDSA), issued strong condemnations of the proposed vaccine schedule. They warned that the changes would significantly increase the risk of preventable disease outbreaks and undermine decades of public health progress. These groups called for immediate legal action to prevent the implementation of what they deemed dangerous and scientifically unfounded policies.

via axios.com·theguardian.com·firstwordpharma.com

Health Secretary Robert F. Kennedy Jr. publicly endorsed the new Advisory Committee on Immunization Practices (ACIP) recommendations for a revised childhood vaccine schedule. He stated that the changes reflected a commitment to 'individualized health choices' and would be implemented pending a brief public comment period. Kennedy's endorsement signaled the administration's intent to push forward with the controversial changes despite widespread opposition from mainstream medical organizations.

via axios.com·theguardian.com·firstwordpharma.com

After months of deliberation and public hearings, the Advisory Committee on Immunization Practices (ACIP) formally voted to recommend a drastically revised childhood vaccine schedule. The new recommendations included a significant reduction in the total number of recommended shots and, notably, the elimination of the universal Hepatitis B vaccine for all babies. This vote represented a major shift from decades of established public health policy and was immediately controversial.

via axios.com·theguardian.com·firstwordpharma.com

2025

14 updates

President Trump issued a memorandum directing Health Secretary Kennedy and the CDC director to conduct a thorough review of all U.S. childhood vaccination recommendations. The order aimed to align the U.S. schedule with 'best practices' from other developed countries, particularly after Kennedy's handpicked ACIP began discussing significant changes. This presidential directive provided further political backing for Kennedy's efforts to revise the national immunization guidelines.

via axios.com·theguardian.com·firstwordpharma.com

A draft of the Advisory Committee on Immunization Practices (ACIP) recommendations was leaked to the press, revealing proposals for significant reductions in the number of routinely recommended childhood vaccines. Key changes included the potential removal of the Hepatitis B vaccine for all infants and a reduced schedule for several other common immunizations. The leak ignited a firestorm of criticism from the medical community, which condemned the proposals as dangerous and scientifically unfounded.

via axios.com·theguardian.com·firstwordpharma.com

The newly appointed Advisory Committee on Immunization Practices (ACIP) held a series of public hearings to solicit input on potential revisions to the childhood vaccine schedule. These hearings were characterized by heated debate, with many medical experts and parents expressing strong opposition to any reductions in recommended vaccines. Conversely, a vocal minority supported the proposed changes, echoing Secretary Kennedy's skepticism about the current schedule.

via axios.com·theguardian.com·firstwordpharma.com

The Department of Health and Human Services (HHS) officially announced a comprehensive, top-to-bottom review of the entire U.S. childhood immunization schedule. Secretary Kennedy stated that the review aimed to ensure the schedule was 'optimized for child health and safety,' implying potential changes to the long-standing recommendations. This announcement intensified concerns among medical professionals who viewed it as a direct threat to established public health protocols.

via axios.com·theguardian.com·firstwordpharma.com

Leading public health experts and epidemiologists issued stark warnings about the potential for resurgent outbreaks of vaccine-preventable diseases, such as measles and mumps. They attributed this risk to declining public confidence in vaccines, fueled by Secretary Kennedy's rhetoric and policy changes. These warnings highlighted the critical importance of maintaining high vaccination rates to preserve herd immunity and protect vulnerable populations.

via axios.com·theguardian.com·firstwordpharma.com

The American Academy of Pediatrics (AAP) and other medical organizations filed a lawsuit against Health Secretary Kennedy and the Department of Health and Human Services (HHS). The initial legal challenge focused on Kennedy's directive to remove COVID-19 vaccines from the CDC's immunization schedule for children and pregnant women. This lawsuit marked the beginning of a concerted legal effort by medical groups to counter Kennedy's controversial changes to federal vaccine policy.

via axios.com·theguardian.com·firstwordpharma.com

The newly reconstituted Advisory Committee on Immunization Practices (ACIP) held its first meeting, which included discussions on COVID-19 vaccinations. This meeting took place after Secretary Kennedy had already bypassed the panel to announce that COVID-19 vaccines would no longer be universally recommended for healthy children or pregnant women. Despite the new committee's skepticism, CDC scientists presented data at the meeting underscoring the protective benefits of COVID-19 vaccines.

via axios.com·theguardian.com·firstwordpharma.com

Under the direction of Secretary Kennedy, the CDC Director issued new guidance that questioned the universal recommendation for COVID-19 vaccination in healthy children and pregnant women. This guidance diverged significantly from previous CDC recommendations and international health standards. It suggested a more individualized approach, citing evolving data and potential risks, despite widespread scientific consensus on the benefits of these vaccines for broad populations.

via axios.com·theguardian.com·firstwordpharma.com

Following the mass dismissal of the previous ACIP members, Secretary Kennedy began appointing his own selections to the committee. Many of these new appointees were known for expressing anti-vaccine sentiments, raising significant alarm among public health experts and medical professionals. These appointments would later be challenged in court, with a judge ultimately ruling them likely in violation of federal law.

via axios.com·theguardian.com·firstwordpharma.com

Health Secretary Robert F. Kennedy Jr. announced the removal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), the scientific body that advises the CDC on vaccine use. Kennedy justified this unprecedented move by citing a need to restore public confidence in vaccine science and alleging conflicts of interest among the previous members. This decision drew immediate and strong criticism from major medical and public health organizations, who viewed it as a politically motivated attack on scientific integrity.

via axios.com·theguardian.com·firstwordpharma.com

The Department of Health and Human Services (HHS) announced its intention to restructure the Advisory Committee on Immunization Practices (ACIP), the independent expert panel that advises the CDC. Secretary Kennedy stated that the committee needed 'fresh perspectives' and a more diverse range of viewpoints to better serve the American public. This announcement was met with apprehension by the medical community, which feared it was a prelude to removing established experts and appointing individuals aligned with Kennedy's controversial views.

via axios.com·theguardian.com·firstwordpharma.com

During a public address and subsequent media interviews, Secretary Kennedy openly questioned the long-term efficacy and safety of several routinely administered childhood vaccines. He suggested that the current immunization schedule might be overly aggressive and called for more research into potential adverse effects. These statements sparked immediate backlash from medical professionals and public health organizations, who reiterated the scientific consensus on vaccine safety and effectiveness.

via axios.com·theguardian.com·firstwordpharma.com

Shortly after his confirmation, Secretary Kennedy initiated a comprehensive internal review of vaccine policies and procedures within the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). This review was framed as an effort to enhance transparency and public trust in federal health agencies. Critics, however, viewed it as a preliminary step to dismantle established public health guidelines and introduce his personal skepticism into official policy.

via axios.com·theguardian.com·firstwordpharma.com

Robert F. Kennedy Jr. was confirmed as the 26th United States Secretary of Health and Human Services by the U.S. Senate, following a 52-48 vote. His confirmation came after weeks of intense debate, with many expressing concerns about his long-standing views on vaccine safety and skepticism towards scientific research. As head of HHS, Kennedy gained oversight of a vast agency, including key public health bodies like the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA).

via axios.com·theguardian.com·firstwordpharma.com

Story began · 1 year, 1 mo ago